People living with LHON suffer from rapid and severe loss of central vision due to mitochondrial dysfunction of retinal ganglion cells.1 Idebenone has the potential to be the first and only clinically ...

WASHINGTON -- Patients with Duchenne muscular dystrophy (DMD) who took the oral drug idebenone for 12 months showed significantly less decline in standard respiratory function measures including peak ...

Idebenone is recommended, within its marketing authorisation, as an option for treating visual impairment in Leber's hereditary optic neuropathy (LHON) in people 12 years and over. Idebenone is ...

In an animal model of Duchenne muscular dystrophy, Brazilian researchers tested a therapy that combines photobiomodulation using laser light or light-emitting diodes (LEDs) with idebenone, an ...

Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Idebenone - Drug Insight and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. Idebenone - Emerging Insight and Market ...

The goal of this randomized, double-blind, placebo-controlled intervention trial was to evaluate the efficacy of idebenone, a synthetic analogue of coenzyme Q10, on neurological function in patients ...

A Prescription Drug User Fee Act target date of February 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

Please provide your email address to receive an email when new articles are posted on . Idebenone has a Prescription Drug User Fee Act date of Feb. 28, 2026. Positive results in the phase 3 RHODOS and ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

There is a simple discount patient access scheme for idebenone. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...